Home > Financial Ratios > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Core EBITDA Margin

    Back to All Ratios
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GUJARAT THEMIS BIOSYN
Please provide your vote to see the results

GUJARAT THEMIS BIOSYN Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 46.3649.6250.5444.5337.40

What is the latest Core EBITDA Margin ratio of GUJARAT THEMIS BIOSYN ?

The latest Core EBITDA Margin ratio of GUJARAT THEMIS BIOSYN is 46.36 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar202446.36
Mar202349.62
Mar202250.54
Mar202144.53
Mar202037.40

How is Core EBITDA Margin of GUJARAT THEMIS BIOSYN Trending?

Years Core EBITDA Margin % Change
Mar2024 46.36
-6.57
Mar2023 49.62
-1.82
Mar2022 50.54
13.50
Mar2021 44.53
19.06
Mar2020 37.4 -

Other Financial Ratios of GUJARAT THEMIS BIOSYN


Compare Core EBITDA Margin ratio of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹3,997.0 Cr 1.8% 16.4% 15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

1.8%

16.4%

15.3%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses